Outcome of Pleural Empyema Treated With Video-Assisted Thoracoscopic Surgery in Patients With Severe Co-Morbidities: An Observational Study

• DOI: 10.2147/mder.s498901
• Publication Date: 2025-01-31T10:10:11Z
• Authors: Hai Vu; Nam Nguyen; Tuan Le; Son Nguyen; Anh Viet Le; Anh The Vu; Ba Van Nguyen; Binh Van Nguyen; Nam Thanh Quan; Nguyen An; Thuan Duc Nghiem
• Keywords: Video-assisted thoracoscopic surgery; Thoracoscopy; Pleural empyema; Cardiothoracic surgery

Empyema patients with poor physical condition and severe comorbidities face a significant challenge, difficulties in choosing appropriate treatment methods, limited outcomes, high rate of complications mortality. To comment on the indications to evaluate outcomes pleural empyema by thoracoscopic surgery. An observational study 12 treated at Department Thoracic Surgery - Military Hospital 103, from January 2017 December 2022. The mean age was 63.4 ± 12.4 years old, male/female ratio 5/1. In this study, 83.3% cases were presented stage II empyema. Karnofsky score 50.0 6.1. Some contained chronic obstructive pulmonary disease (COPD) (25.0%), spontaneous esophageal perforation (16.7%), liver cancer, cirrhosis, end-stage renal failure dialysis (8.7%). surgery procedures efficient short duration (65.6 9.4 minutes), low incidence blood transfusion (8.3%), lower postoperative (surgical wound infection 8.3%). length stay 16.8 9.9 days. Pleural drainage removed 11 out after an average 60.1 8.5 days, while one patient had their retained due cancer. total recovery 1-year follow-up 91.7%. Video-Assisted Thoracoscopic (VATS) exhibits positive treating I who incurred comorbidities.